KXAN

LUMA Vision Receives FDA Clearance for VERAFEYE 2D/4D Cardiac Visualization Platform

Real-Time, 360-Degree Imaging Enhances Precision and Confidence in Cardiac Procedures DUBLIN, April 16, 2025 /PRNewswire/ -- LUMA Vision Ltd., an innovative leader in advanced cardiac imaging and ...
Morningstar

LUMA Vision to Showcase VERAFEYE 4D Imaging Platform at HRS 2026, Signaling a New Foundation for EP Guidance

DUBLIN, April 21, 2026 /PRNewswire/ -- LUMA Vision, a leader in real-time 4D cardiac imaging and navigation, today announced its participation in the Heart Rhythm Society Annual Meeting (HRS 2026) in ...
KXAN

LUMA Vision Successfully Completes First-in-Human Procedures with its Novel VERAFEYE™ Navigation and Visualization Platform

DUBLIN, Jan. 14, 2025 /PRNewswire/ -- LUMA Vision Ltd., an innovative leader in Cardiac Navigation and Visualization technology, proudly announces the successful first-in-human use and enrollment in ...
PR Newswire

Precision Redefined: LUMA Vision Completes VERAFEYE™ 4D-Guided Persistent AF Ablations, Demonstrating a Significant Advancement in Simplifying Image-Guided Cardiac Care

DUBLIN, Jan. 7, 2026 /PRNewswire/ -- LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 VERAFEYE™-guided persistent atrial fibrillation ...
Morningstar

LUMA Vision VERAFEYE System to be Featured at AF Symposium In Recorded Case Presentation

DUBLIN, Feb. 2, 2026 /PRNewswire/ -- LUMA Vision Ltd., a leader in next-generation cardiac 4D navigation and imaging, today announced that its proprietary VERAFEYE™ System will be showcased in a ...